Biomed Group
Long/short equity, healthcare, biotech

Five Prime: A Growing Oncology And Inflammatory Player With A Promising Pipeline

Once a rarely used subset of medical treatments, protein therapeutics have increased dramatically in number and frequency of use since the introduction of the first recombinant protein therapeutic - human insulin - 25 years ago. Protein therapeutics already have a significant role in almost every field of medicine, but this role is still only in its infancy. In this article, we decided to evaluate Five Prime Therapeutics (NASDAQ:FPRX), a small-cap biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases.

Company Overview

Five Prime was incorporated in Delaware in 2001 and is headquartered in South San Francisco, California. Five Prime has developed the industry's most comprehensive protein library consisting of more than 5,600...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details